Clinical Trials Sponsored by BioGene Life Science

Total 841 results

LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

Colon Resection | _large Interstinal Surgery

Korea, Republic of
LG Life Sciences

Unknown

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Korea, Republic of
LG Life Sciences

Completed

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Unknown

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B (LB80380)

Chronic Hepatitis B

China, Korea, Republic of
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

Russian Federation
Achieve Life Sciences

Terminated

Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer

Breast Neoplasm

United States
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

Ovarian Cancer
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Russian Federation
Vigonvita Life Sciences

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Respiratory Syncytial Virus Infections

China
CND Life Sciences

Recruiting

The Syn-Sleep Study

REM Sleep Behavior Disorder (iRBD)

United States
Receptor Life Sciences

Withdrawn

Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Achieve Life Sciences

Completed

A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers (ORCA-3)

Smoking Cessation

United States
CND Life Sciences

Completed

Synuclein-One Study

Parkinson Disease | Multiple System Atrophy | Pure Autonomic Failure | Dementia With Lewy Bodies

United States
Achieve Life Sciences

Completed

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Renal Impairment

Spain, Portugal
Vigonvita Life Sciences

Completed

Drug-Drug Interaction (DDI) Study for TPN171H

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Effect of TPN171H on Spermatogenesis

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

COVID-19

China
Vigonvita Life Sciences

Completed

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Erectile Dysfunction | Alcohol | Phosphodiesterase Inhibitor

China
Vigonvita Life Sciences

Completed

Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers

Healthy Subjects

China
Achieve Life Sciences

Completed

Trial of Cytisine in Adult Smokers

Smoking Cessation

United States
Achieve Life Sciences

Completed

A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Smoking Cessation

United Kingdom
LG Life Sciences

Completed

Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold Injection

Temporary Correction of Wrinkles
LG Life Sciences

Completed

Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study

Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 Study

Korea, Republic of
LG Life Sciences

Completed

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Pneumococcal Infections

Korea, Republic of
Transparency Life Sciences

Unknown

Decentralized Dietary UC Pilot Trial

Colitis, Ulcerative

United States
LG Life Sciences

Unknown

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Completed

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Hypertension | Hyperlipidemia

Korea, Republic of
LG Life Sciences

Completed

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Korea, Republic of
LG Life Sciences

Completed

Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)

Infectious Diseases

Korea, Republic of
LG Life Sciences

Completed

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Hyperuricemia | Gout

Korea, Republic of
LG Life Sciences

Completed

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

Osteoarthritis of the Knee

Korea, Republic of
LG Life Sciences

Completed

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

Healthy

Korea, Republic of
LG Life Sciences

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
LG Life Sciences

Completed

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
SK Life Science, Inc.

Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Seizures | Lennox Gastaut Syndrome

United States, Korea, Republic of, Taiwan, Colombia, Israel, Poland, Serbia, Mexico, Argentina, Spain, Greece, Italy, Portugal, Germany
SK Life Science, Inc.

Recruiting

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Partial Epilepsy

United States, Spain, Korea, Republic of, Germany, Australia, Poland, Hungary
SK Life Science, Inc.

Completed

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

Lennox Gastaut Syndrome

United States
GeneOne Life Science, Inc.

Active, not recruiting

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

COVID-19 | Healthy

Puerto Rico, United States
SK Life Science, Inc.

Completed

Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

Lennox Gastaut Syndrome

United States
SK Life Science, Inc.

Completed

A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 mg Cenobamate Administered Orally

Healthy Volunteers

United States
GeneOne Life Science, Inc.

Terminated

GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)

SARS-CoV 2 | Infection

United States
GeneOne Life Science, Inc.

Active, not recruiting

GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)

SARS-CoV-2

Korea, Republic of
SK Life Science, Inc.

Completed

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Partial Epilepsy

Korea, Republic of, United States, India, Poland
SK Life Science, Inc.

Completed

An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).

Neuralgia | Herpes Zoster | Postherpetic Neuralgia
SK Life Science, Inc.

Completed

Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).

Diabetic Neuropathy, Painful | Diabetic Polyneuropathy | Diabetic Neuralgia | Diabetic Mononeuropathy

3

Subscribe